1. Therapeutic Goods Administration. Medicinal Cannabis Special Access Scheme Category B data. Medicinal Cannabis 2023. https://www.tga.gov.au/medicinal-cannabis-special-access-scheme-category-b-data. Accessed 24 May 2023
2. Therapeutic Goods Administration. Medicinal cannabis: Access pathways and patient access data. Medicinal cannabis hub 2023. https://www.tga.gov.au/products/unapproved-therapeutic-goods/medicinal-cannabis-hub/medicinal-cannabis-access-pathways-and-patient-access-data. Accessed 24 May 2023
3. Broyd SJ, van Hell HH, Beale C, Yucel M, Solowij N. Acute and chronic effects of cannabinoids on human cognition-a systematic review. Biol Psychiatry. 2016;79(7):557–67. https://doi.org/10.1016/j.biopsych.2015.12.002.
4. Bridgeman MB, Abazia DT. Medicinal cannabis: history, pharmacology, and implications for the acute care setting. P T. 2017;42(3):180–8.
5. Moriarty O, McGuire BE, Finn DP. The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol. 2011;93(3):385–404. https://doi.org/10.1016/j.pneurobio.2011.01.002.